Reduced levels of L-carnitine might lower fatty acid oxidation and could function as a contributing factor in liver fat accumulation; moreover, supplementation with L-carnitine might reduce liver fat and liver ALT and AST levels in NAFLD patients [34]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.